Heredera Breast Cancer: Phase Iii Study Of First-Line, Fixed-Dose Combination Of Pertuzumab And Trastuzumab For Subcutaneous Injection +- Giredestrant (Gdc-9545) For Estrogen Receptor+, Her2+ Advanced Breast Cancer
Pertuzumab;Trastuzumab;Giredestrant
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Heredera Breast Cancer: Phase Iii Study Of First-Line, Fixed-Dose Combination Of Pertuzumab And Trastuzumab For Subcutaneous Injection +- Giredestrant (Gdc-9545) For Estrogen Receptor+, Her2+ Advanced Breast Cancer ### Output: Pertuzumab;Trastuzumab;Giredestrant